Botulinum toxin A as an alternative treatment for folliculitis decalvans
Open Access
- 11 March 2023
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 35, 77-79
Abstract
No abstract availableKeywords
Funding Information
- Fundação Butantan
This publication has 9 references indexed in Scilit:
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic AlopeciaBioMed Research International, 2020
- Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-upJournal of the American Academy of Dermatology, 2018
- Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive InfectionCell, 2018
- Botulinum Toxin as a Pain Killer: Players and Actions in AntinociceptionToxins, 2015
- Folliculitis decalvans: a multicentre review of 82 patientsJournal of the European Academy of Dermatology and Venereology, 2015
- Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-standing Cases.2014
- Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axisFrontiers in Neuroscience, 2014
- Folliculitis decalvansDermatologic Therapy, 2008
- A Hot New Twist to Hair BiologyThe American Journal of Pathology, 2005